Therapeutic strategy for postoperative recurrence in patients with non-small cell lung cancer
about
The Role of PET/CT Molecular Imaging in the Diagnosis of Recurrence and Surveillance of Patients Treated for Non-Small Cell Lung CancerAccelerated radiotherapy and concurrent chemotherapy for patients with contralateral central or mediastinal lung cancer relapse after pneumonectomyThe biological role of actinin-4 (ACTN4) in malignant phenotypes of cancerCharacterization of different CTC subpopulations in non-small cell lung cancer.Sinomenine inhibits A549 human lung cancer cell invasion by mediating the STAT3 signaling pathway.Nanomedicine as an emerging platform for metastatic lung cancer therapy.Combined RNAi targeting human Stat3 and ADAM9 as gene therapy for non-small cell lung cancer.Specific KRAS amino acid substitutions and EGFR mutations predict site-specific recurrence and metastasis following non-small-cell lung cancer surgery.Survival and prognostic factors of non-small cell lung cancer patients with postoperative locoregional recurrence treated with radical radiotherapy.Surgery combined with adenoviral p53 gene therapy for treatment of non-small cell lung cancer: a phase II study.Salvage chemoradiotherapy with cisplatin and vinorelbine for postoperative locoregional recurrence of non-small cell lung cancer.Body mass index, C-reactive protein and survival in smokers undergoing lobectomy for lung cancer†.
P2860
Q28066013-6B16B0E7-772A-4C6F-95AA-CB75438C8497Q35290831-C349F0B9-1B18-4069-A411-D4BB5B7D9C6DQ35964611-CEE9A1B3-D20B-4741-8E8E-3351924DE943Q37005619-7177205D-5990-4452-80DB-66B74BBF5E98Q37108420-F9D950CF-C42B-4603-898D-E497BA4D831FQ38463092-20AA15A9-D079-4FBF-BBE9-1A1E093B0E44Q38792740-A99093F2-31B1-4C86-A8C2-93AC6AFEEDB9Q39660590-2FB8E791-400E-40D4-B783-879723C6A86DQ47099923-DE875A5B-24FD-4326-9F3B-D58794802D40Q47122526-B8C3DC9A-B907-482C-8756-A033D3671262Q47353436-253A8357-D5FE-4BD8-86B1-E5B777158693Q51136992-23304AED-F4A8-40FE-8FAF-6E45EF2E5D61
P2860
Therapeutic strategy for postoperative recurrence in patients with non-small cell lung cancer
description
2014 nî lūn-bûn
@nan
2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Therapeutic strategy for posto ...... ith non-small cell lung cancer
@ast
Therapeutic strategy for posto ...... ith non-small cell lung cancer
@en
Therapeutic strategy for posto ...... ith non-small cell lung cancer
@nl
type
label
Therapeutic strategy for posto ...... ith non-small cell lung cancer
@ast
Therapeutic strategy for posto ...... ith non-small cell lung cancer
@en
Therapeutic strategy for posto ...... ith non-small cell lung cancer
@nl
prefLabel
Therapeutic strategy for posto ...... ith non-small cell lung cancer
@ast
Therapeutic strategy for posto ...... ith non-small cell lung cancer
@en
Therapeutic strategy for posto ...... ith non-small cell lung cancer
@nl
P2860
P3181
P356
P1476
Therapeutic strategy for posto ...... ith non-small cell lung cancer
@en
P2093
Tokujiro Yano
P2860
P304
P3181
P356
10.5306/WJCO.V5.I5.1048
P407
P577
2014-12-10T00:00:00Z